-
Mashup Score: 9Health Canada licenses Symplicity Spyral radiofrequency renal denervation system to treat hypertension - Vascular News - 1 month(s) ago
Medtronic has received a license from Health Canada for its Symplicity Spyral multi-electrode renal denervation (RDN) system. This is indicated for the management of essential hypertension in patients for whom blood pressure remains uncontrolled despite lifestyle modifications and guideline-driven medical therapy with antihypertensive medications, or when guideline-driven therapy is poorly tolerated. The Symplicity blood pressure […]
Source: vascularnews.comCategories: General Medicine News, NephrologyTweet
quickly following US FDA, @GovCanHealth also approves RDN in Canada (or atleast Medtronic SPYRAL) https://t.co/PAA5X8OeTM our write up from #TopNephrology here https://t.co/WEMDCPEEc1 https://t.co/9h7bTJBWi1